Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 157

Results For "Medica"

2472 News Found

Modi Inaugurates hospital complex and CoE in South Gujarat
Public Health | June 11, 2022

Modi Inaugurates hospital complex and CoE in South Gujarat

Centre of Excellence at Kharel comprises Skill-building Centre and Primary, Secondary and Higher Secondary schools


Takeda’s dengue vaccine candidate offers protection against dengue fever in clinical trial
Diagnostic Center | June 11, 2022

Takeda’s dengue vaccine candidate offers protection against dengue fever in clinical trial

TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union


AeroSafe Global appointment Jessica Cao as Sr VP (Marketing)
People | June 11, 2022

AeroSafe Global appointment Jessica Cao as Sr VP (Marketing)

Company hires life science veteran Jessica Cao to join management team


Marinus expands enrollment criteria to support recruitment in Phase 3 RAISE Trial in refractory status epilepticus
Diagnostic Center | June 10, 2022

Marinus expands enrollment criteria to support recruitment in Phase 3 RAISE Trial in refractory status epilepticus

Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.


GE Healthcare’s molecular imaging solutions enable precision health & theranostics for prostate cancer
News | June 10, 2022

GE Healthcare’s molecular imaging solutions enable precision health & theranostics for prostate cancer

Healthcare is timely and personal – and its delivery should be too


National Ayurveda Research Institute for Panchakarma bags NABL Accreditation
News | June 09, 2022

National Ayurveda Research Institute for Panchakarma bags NABL Accreditation

A big boost to healthcare efforts of Ayush through NARIP, CCRAS


Sumitomo Pharma Oncology receives orphan drug designation for the treatment of myelofibrosis
Drug Approval | June 09, 2022

Sumitomo Pharma Oncology receives orphan drug designation for the treatment of myelofibrosis

TP-3654 is currently being evaluated in a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics in patients with intermediate or high-risk primary or secondary myelofibrosis.


Cabinet approves MoU signed between India and USA in health sector
Policy | June 08, 2022

Cabinet approves MoU signed between India and USA in health sector

This MoU will further strengthen relations between India and the USA within the framework of international scientific and technological cooperation in fields of mutual interest.


CerTest Biotec and BD collaborates for molecular diagnostic test for Monkeypox
Diagnostic Center | June 08, 2022

CerTest Biotec and BD collaborates for molecular diagnostic test for Monkeypox

CerTest Biotec uses the BD MAX molecular diagnostic system open system reagent suite to develop RT-PCR detection kit


MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib
News | June 07, 2022

MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib

he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients